Zentalis Pharmaceuticals, Inc.ZNTLNASDAQ
Loading
Cash & Equivalents Over TimeStable
Percentile Rank33
3Y CAGR-17.3%
5Y CAGR-12.8%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
-17.3%/yr
Annual compound
5Y CAGR
-12.8%/yr
Recent deceleration
Percentile
P33
Within normal range
vs 5Y Ago
0.5x
Contraction
Streak
1 yr
Consecutive growthStable
| Period | Value | YoY Change |
|---|---|---|
| 2024 | $33.90M | +20.9% |
| 2023 | $28.04M | -34.9% |
| 2022 | $43.07M | -28.2% |
| 2021 | $59.96M | +9.1% |
| 2020 | $54.95M | -18.3% |
| 2019 | $67.25M | +167.3% |
| 2018 | $25.15M | - |